Position in ETON
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,086,000
New position
Shares Held
30,000
first reported quarter
Ownership
0.105%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#65
of 164 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Sigma Planning Corp holds $10,332,357 across 6 Drug Manufacturers - Specialty & Generic names. ETON ranks #4 (10.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
57,590 | $4,591,650 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
10,008 | $1,686,748 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
20,150 | $1,288,592 | |
| 4 | ETON |
Eton Pharmaceuticals, Inc.
This page
|
30,000 | $1,086,000 | |
| 5 | ZTS |
Zoetis Inc.
|
12,694 | $912,190 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
22,128 | $767,177 |
All Filings in ETON
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,086,000 | 30,000 | Shares | Sole | 2026-08-07 | |
| No filing history on record for this holder in this stock. | ||||||